Notice of Intent To Grant a Partially Exclusive Patent License; Intellikine, Inc., 6399 [E9-2614]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices
all applicable product safety rules as
defined in the CPSA or similar rules,
bans, standards, or regulations under
any other Act enforced by the
Commission will remain prohibited in
accordance with section 19 of the CPSA
as amended by CPSIA.
sroberts on PROD1PC70 with NOTICES
II. The Stay
The United States Consumer Product
Safety Commission hereby stays
applicability to manufacturers,
including importers, of the requirements
for testing and certification 8 of products
set forth in paragraphs 14(a)(1), (2) and
(3) of the CPSA, as amended by
subsection 102(a) of CPSIA, with the
exception of:
(1) The requirements of any CPSC
regulation, or of subsection 14(a) of the
CPSA as it existed prior to amendment
by the CPSIA, for product testing and
certification, including existing
requirements for certification of
automatic residential garage door
openers, bike helmets, candles with
metal core wicks, lawnmowers, lighters,
mattresses, and swimming pool slides; 9
and
(2) The certifications required due to
certain requirements of the Virginia
Graeme Baker Pool & Spa Safety Act
being defined as consumer product
safety ‘‘rules;’’ and
(3) The certifications of compliance
required for ATVs in section 42(a)(2) of
the CPSA which were added by CPSIA;
and
(4) Any voluntary guarantees
provided for in the Flammable Fabrics
Act (‘‘FFA’’) or otherwise (to the extent
a guarantor wishes to issue one); and
(5) The requirements on
manufacturers, including importers, of
children’s products to use third party
laboratories to test and to certify, on the
basis of that testing, compliance of
children’s products with:
• Requirements on the lead content of
paint and other surface coatings
effective for products manufactured
after December 21, 2008;
including a rule declaring a consumer product to
be a banned hazardous product or substance.’’
CPSA at § 14(f)(1), as amended by CPSIA § 102(b).
8 By immediate final rule published November
18, 2008 (73 FR 68,328–32), the Commission
limited the testing and certification requirement to
importers and U.S. domestic manufacturers.
9 Prior to amendment by the CPSIA, § 14(a) of the
CPSA required testing and issuance of a
certification for each product subject to a CPSA
consumer product safety standard, namely a
product subject any requirement of 16 CFR parts
1201 through 1213, e.g., part 1205 for walk-behind
power mowers or part 1211 for automatic
residential garage door operators. Certain CPSC
regulations themselves require certification of
compliance or a statement of conformity. See, e.g.
16 CFR part 1633 for flammability (open flame) of
mattresses or 16 CFR 1500.17(a)(13(i)(B) for candles
made with metal-cored wicks.
VerDate Nov<24>2008
16:35 Feb 06, 2009
Jkt 217001
6399
• Requirements applicable to full-size
and non-full-size cribs and pacifiers
effective for products manufactured
after January 20, 2009;
• Requirements concerning small
parts effective for products
manufactured after February 15, 2009;
and
• Requirements on the lead content of
metal components of children’s metal
jewelry effective for products
manufactured after March 23, 2009.
This action by the Commission does
not stay the requirement that products
meet all applicable product safety rules
as defined in the CPSA or similar rules,
bans, standards, or regulations under
any other Act enforced by the
Commission.
Center, 503 Robert Grant Ave., Silver
Spring, MD 20910–7500.
FOR FURTHER INFORMATION CONTACT: Dr.
Charles Schlagel, Director, Office of
Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave.,
Silver Spring, MD 20910–7500,
telephone: 301–319–7428.
Dated: February 2, 2009.
Todd A. Stevenson,
Secretary, Consumer Product Safety
Commission.
[FR Doc. E9–2590 Filed 2–6–09; 8:45 am]
Notice of Proposed Information
Collection Requests
BILLING CODE 6355–01–P
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent To Grant a Partially
Exclusive Patent License; Intellikine,
Inc.
Department of the Navy, DoD.
Notice.
AGENCY:
ACTION:
SUMMARY: The Department of the Navy
hereby gives notice of its intent to grant
to Intellikine, Inc., a revocable,
nonassignable, partially exclusive
license to practice worldwide the
Government owned inventions
described in U.S. Patent 6,632,789
entitled ‘‘Methods for Modulating T Cell
Responses by Manipulating Intracellular
Signal Transduction’’ issued 14 October
2003 and related foreign filings in the
fields of diagnosis, prevention and/or
treatment of disease in humans and/or
animals utilizing methods for
modulating T cell responses by
manipulating intracellular signals
associated with T cell costimulation.
DATE: Anyone wishing to object to the
grant of this license has fifteen (15) days
from the date of this notice to file
written objections along with
supporting evidence, if any. Written
objections are to be filed with the Office
of Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave.,
Silver Spring, MD 20910–7500,
telephone: 301–319–7428.
ADDRESSES: Written objections are to be
filed with the Office of Technology
Transfer, Naval Medical Research
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Dated: February 3, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate
General’s Corps, U.S. Navy, Federal Register
Liaison Officer.
[FR Doc. E9–2614 Filed 2–6–09; 8:45 am]
BILLING CODE 3810–FF–P
DEPARTMENT OF EDUCATION
Department of Education.
The Director, Information
Collection Clearance Division,
Regulatory Information Management
Services, Office of Management, invites
comments on the proposed information
collection requests as required by the
Paperwork Reduction Act of 1995.
DATES: Interested persons are invited to
submit comments on or before April 10,
2009.
SUPPLEMENTARY INFORMATION: Section
3506 of the Paperwork Reduction Act of
1995 (44 U.S.C. Chapter 35) requires
that the Office of Management and
Budget (OMB) provide interested
Federal agencies and the public an early
opportunity to comment on information
collection requests. OMB may amend or
waive the requirement for public
consultation to the extent that public
participation in the approval process
would defeat the purpose of the
information collection, violate State or
Federal law, or substantially interfere
with any agency’s ability to perform its
statutory obligations. The Director,
Regulatory Information Management
Services, Office of Management,
publishes that notice containing
proposed information collection
requests prior to submission of these
requests to OMB. Each proposed
information collection, grouped by
office, contains the following: (1) Type
of review requested, e.g., new, revision,
extension, existing or reinstatement; (2)
Title; (3) Summary of the collection; (4)
Description of the need for, and
proposed use of, the information; (5)
Respondents and frequency of
collection; and (6) Reporting and/or
Recordkeeping burden. OMB invites
public comment.
The Department of Education is
especially interested in public comment
AGENCY:
SUMMARY:
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 74, Number 25 (Monday, February 9, 2009)]
[Notices]
[Page 6399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2614]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent To Grant a Partially Exclusive Patent License;
Intellikine, Inc.
AGENCY: Department of the Navy, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to Intellikine, Inc., a revocable, nonassignable, partially
exclusive license to practice worldwide the Government owned inventions
described in U.S. Patent 6,632,789 entitled ``Methods for Modulating T
Cell Responses by Manipulating Intracellular Signal Transduction''
issued 14 October 2003 and related foreign filings in the fields of
diagnosis, prevention and/or treatment of disease in humans and/or
animals utilizing methods for modulating T cell responses by
manipulating intracellular signals associated with T cell
costimulation.
DATE: Anyone wishing to object to the grant of this license has fifteen
(15) days from the date of this notice to file written objections along
with supporting evidence, if any. Written objections are to be filed
with the Office of Technology Transfer, Naval Medical Research Center,
503 Robert Grant Ave., Silver Spring, MD 20910-7500, telephone: 301-
319-7428.
ADDRESSES: Written objections are to be filed with the Office of
Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave., Silver Spring, MD 20910-7500.
FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave., Silver Spring, MD 20910-7500, telephone: 301-319-7428.
Dated: February 3, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy,
Federal Register Liaison Officer.
[FR Doc. E9-2614 Filed 2-6-09; 8:45 am]
BILLING CODE 3810-FF-P
